Motivation Skills Training for adults with schizophrenia
Motivation Skills Training to Enhance Functional Outcomes for People With Schizophrenia
NA · Columbia University · NCT05805397
This study is testing a new training program to help adults with schizophrenia boost their motivation and daily functioning compared to a group focusing on healthy behaviors.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Columbia University (other) |
| Locations | 2 sites (New York, New York and 1 other locations) |
| Trial ID | NCT05805397 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of Motivation Skills Training (MST) compared to a Healthy Behaviors Control (HBC) group for adults diagnosed with schizophrenia or schizoaffective disorder. The study will involve 80 participants who will undergo baseline assessments and then participate in weekly group therapy sessions over a 12-14 week period. MST focuses on enhancing motivation knowledge and self-regulation skills to improve daily functioning and goal attainment, while HBC emphasizes physical health. The trial aims to establish the feasibility, acceptability, and pilot effectiveness of MST in improving motivation and related outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 with a DSM-5 diagnosis of schizophrenia or schizoaffective disorder who are medically and psychiatrically stable.
Not a fit: Patients with severe cognitive impairment, intellectual disabilities, or significant substance use issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance motivation and daily functioning for patients with schizophrenia.
How similar studies have performed: While the approach of MST is novel, other studies have indicated that addressing motivational deficits in schizophrenia can lead to improved outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18-65 2. DSM-5 Diagnosis of Schizophrenia or Schizoaffective Disorder 3. Medically and psychiatrically stable outpatient status 4. English Fluency Exclusion Criteria: 1. Indications of Intellectual Disability as documented in medical history or measured by \< 70 premorbid full scale Intelligence Quotient (IQ) estimate 2. Severe substance use within the past three months determined by DSM-5 criteria 3. Neurologic condition causing brain disease 4. Mild to severe cognitive impairment associated with possible dementia measured by a Mini Mental Status Exam score below 20 in individuals ages 60 and older
Where this trial is running
New York, New York and 1 other locations
- The Bridge, Inc. — New York, New York, United States (RECRUITING)
- New York State Office of Mental Health — New York, New York, United States (NOT_YET_RECRUITING)
Study contacts
- Principal investigator: Alice Saperstein, PhD — Columbia University
- Study coordinator: Alice Saperstein, PhD
- Email: Alice.Saperstein@nyspi.columbia.edu
- Phone: 646-774-8464
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Schizophrenia, Schizoaffective Disorder, Mental Illness, Motivation Skills